From discovery to real-world application, verifiably.
Sciencera is the compliance-first, community-owned network for translating peptide science into real products across human health, agriculture, veterinary, aquaculture, industrial biotech, and cosmetics.
The world does not suffer from a shortage of biological ideas. It suffers from broken translation.
Every year, researchers identify peptides that could reshape medicine, agriculture, veterinary care, aquaculture, industrial materials, and cosmetics. The problem is not discovery.
Between a promising peptide and a real-world product lies a fragmented, slow, and opaque path. Data disappears into PDFs. Lab work is hard to verify. Funding decisions happen behind closed doors. IP ownership is unclear.
never reach clinical or field validation.
in human therapeutics, with opaque progress along the way.
across labs, funders, regulators, and buyers with no shared truth.
sits in silos, unseen by the people who could build on it.
A network where peptide science becomes translatable at scale.
Sciencera is not just a research portal, a funding protocol, or an IP marketplace. It is full-stack translation infrastructure — from hypothesis to patient, farm, factory, and formulation.
Submit hypotheses, receive structured peer review, raise milestone-based funding, contract verified labs, validate results, and publish with immutable provenance.
See exactly what was proposed, what evidence supports it, which lab performed the work, whether milestones were met, and how value flows — transparently.
Build durable reputation through verified execution, not marketing. Attestations become on-chain signals that compound over time.
Inspect an auditable trail of claims, attestations, study records, and quality controls. Compliance is designed in, not bolted on.
Access validated peptide assets, datasets, and development partners. Every claim is backed by traceable evidence, from synthesis to field.
Distinguish hype from validated peptide science. Follow research from hypothesis to product. See where your food, medicine, and materials actually come from.
A network, not a linear product.
Ten modules across seven layers, each designed to make a specific part of biotech translation verifiable, fundable, and open.
Hypothesis submission, structured peer review, AI-assisted drafting with PubMed, AlphaFold, and UniProt integration.
Stablecoin escrow with staged capital release tied to verifiable deliverables.
Verified CRO registry with GMP and GLP services, synthesis, assays, and on-chain provenance.
IP-NFTs and licensing marketplace — activated only after scientific gates, never before.
Curated peptide database, industry RFP portal, and API access to validated datasets.
Soulbound credentials for researchers, labs, reviewers, instructors, and contributors.
Training in peptide science, DeSci, GMP and GLP, regulatory, clinical, and vertical applications.
Clinical trials, field trials, veterinary testing, aquaculture validation, industrial pilots.
Cross-vertical supply chain with provenance, anti-counterfeit, batch tracking, and cold chain.
Real-world data capture that returns to improve hypotheses, reputations, and regulation.
Peptides are not confined to hospitals.
The same translation infrastructure serves different regulatory paths because the core problem is shared: evidence, funding, validation, rights, distribution, and feedback.
Metabolic therapy (GLP-1), oncology, antimicrobial, vaccines, wound healing.
A GLP-1 project moves from receptor modeling to synthesis, preclinical testing, IP structuring, and clinical readiness.
Antimicrobial peptides replacing antibiotics, peptide vaccines, herd health.
A livestock cooperative funds an AMP program with transparent validation and farm-level outcome tracking.
Biopesticides, plant defense activators, crop enhancers, stress resistance.
A rice disease peptide is reviewed by plant scientists, tested in greenhouses, then validated in the field with traceable provenance.
Disease resistance, antimicrobial peptides for fish and shrimp, pathogen control.
A marine-derived peptide is tested for shrimp survival with on-chain farm-level data feeding back to the research.
Biomaterials, biosensors, enzymes, binding agents, food preservation.
A peptide-based biosensor passes performance validation and enters manufacturing integration with buyer-side attestations.
Anti-aging, collagen signaling, pigmentation, barrier support.
A collagen-signaling ingredient is linked to identity, testing records, and batch provenance — not just marketing claims.
Others stop at funding, IP, or speculation. We stop at the patient, the farm, the factory.
The gap in the market is the full journey — discovery to feedback, across every vertical where peptides matter.
Credibility before capital intensity.
We build the trust layer first, then funding, then lab validation, then IP and data, then application and distribution.
- Regulatory mapping across verticals
- Governance design
- Data architecture
- Scientific review framework
- Hypothesis submission
- Peer review workflows
- Academy tracks launch
- Soulbound reputation credentials
- Verified CRO registry
- Stablecoin escrow
- Lab attestations
- Synthesis and assay workflows
- IP-NFT infrastructure
- Licensing marketplace
- Data Marketplace with institutional RFPs
- Network token readiness
- Healthcare clinical pilots
- Agriculture field trials
- Veterinary trials
- Industrial performance pilots
- Provenance tracking
- Anti-counterfeit systems
- Cold chain verification
- Batch records across verticals
- Real-world data capture
- Cross-vertical expansion
- Global partner network
- Mature governance
Progressive. Not speculative.
Sciencera’s token model evolves with network maturity. We never launch liquidity before legitimacy. Blockchain is a verification layer, not the product.
Non-transferable credentials for researchers, reviewers, labs, instructors, and contributors. Trust cannot be bought from someone else.
Transparent records of who supported which deliverables. Coordination tools — not casino chips.
Issued only after scientific gates are passed. Tokenized ownership must follow evidence, rights clarity, and compliance review.
Issued after real usage exists — active projects, labs, data customers, institutional partners. Never a substitute for product-market fit.
The strongest version of Sciencera does not depend on token appreciation. It earns revenue by making translation work — protocol fees, marketplace take rate, IP licensing, SaaS, premium data, testing fees, distribution services, and institutional training.